Shionogi & Co. Ltd.

In News

Shionogi CEO says firm is pursuing acquisitions and mulling expanded U.S. production - The Japan Times

The Japan Times - Aug 05, 2026

Watch Shionogi Eyes More US Plants, M&A Deals - Bloomberg.com

Bloomberg.com - Aug 05, 2026

Shionogi (TSE:4507) Starts U.S. XOCOVA Sales As Strong Q1 Results Put Valuation In Focus - simplywall.st

simplywall.st - Aug 07, 2026

Shionogi makes the call on COVID pill Xocova TV spot - Fierce Pharma

Fierce Pharma - Jul 30, 2026

Shionogi & Co., Ltd. 2027 Q1 - Results - Earnings Call Presentation (OTCMKTS:SGIOY) 2026-08-06 - Seeking Alpha

Seeking Alpha - Aug 06, 2026

Shionogi & Co. Profit Rises 91% in Fiscal Q1 - Moomoo

Moomoo - Aug 04, 2026

Shionogi weighs future of FXS drug after double Phase III miss - Clinical Trials Arena

Clinical Trials Arena - May 14, 2026

Shionogi Secures US Contract to Expand Antibiotic Manufacturing and Biothreat Preparedness - Contagion Live

Contagion Live - Apr 09, 2026

Shionogi’s Q1 Earnings Surge on Acquisitions, HIV Royalties and Overseas Growth - The Globe and Mail

The Globe and Mail - Aug 04, 2026

Shionogi & Co: Record Q1 revenue and profit driven by acquisitions and global sales growth - TradingView

TradingView - Aug 03, 2026

Shionogi secures BARDA contract for cefiderocol for resistant infections, bioterror threats - CIDRAP

CIDRAP - Apr 09, 2026

Shionogi Inc. Awarded $482 Million Contract with U.S. Government to Enhance National Preparedness for Drug-Resistant Bacterial Threats - Pharmaceutical Executive

Pharmaceutical Executive - Apr 09, 2026

Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.

AI Sentiment